Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA and CoQ-10 for Vestibular Function
NCT05945160Phase 1Withdrawn
- Sponsor
- UT Health San Antonio
- Start
- Jan 2024
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in vestibular dysfunction (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Slow Harmonic Acceleration at 12 months. Planned start Jan 2024; status: withdrawn.
02
Conditions
vestibular dysfunction
Beyond the preview
Go deeper on NCT05945160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05945160.